SCHEMBL9544779

SCHEMBL9544779

CC(C)(C)OC(=O)N1CCC[C@@H]1C(=O)OC(=O)[C@H]1CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.59
SMN1; SMN2 Q16637 1/20 0.55
NPC1 O15118 1/20 0.52
LMNA P02545 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
EPHX2 P34913 1/20 0.49
UCHL1 P09936 1/20 0.48
KLK7 P49862 1/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
POLB P06746 1/20 0.46
SCN4A P35499 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6219879 1.00 HSD17B10 (0.59) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL23477366 1.00 HSD17B10 (0.59) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL9727398 1.00 HSD17B10 (0.59) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL18353935 0.93 HSD17B10 (0.56) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL895773 0.92 HSD17B10 (0.61) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL7286305 0.92 HSD17B10 (0.61) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL19414808 0.92 HSD17B10 (0.61) HSD17B10SMN1; SMN2NPC1LMNANPSR1
Ammonia Solution, Strong SCHEMBL1963768 0.91 HSD17B10 (0.54) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL12894181 0.91 HSD17B10 (0.54) HSD17B10SMN1; SMN2NPC1LMNANPSR1
SCHEMBL28133679 0.90 HSD17B10 (0.62) HSD17B10SMN1; SMN2NPC1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3256466-B9 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC (US) 2022-07-27 EP disclosed
EP-3256466-B1 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC (US) 2022-04-06 EP disclosed
EP-3873938-A1 DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS Novartis AG (CH) 2021-09-08 EP disclosed
CN-113348181-A DC-SIGN antibody conjugates comprising a STING agonist 诺华股份有限公司 2021-09-03 CN disclosed
CN-110799218-A Antibody conjugates comprising STING agonists 诺华股份有限公司 2020-02-14 CN disclosed
EP-3256466-A1 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS Sunovion Pharmaceuticals Inc. (US) 2017-12-20 EP disclosed
WO-2016130796-A1 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2016-08-18 WO disclosed
WO-1993020818-A1 SUBSTITUTED INDOLIZINO[1,2-b]QUINOLINONES SMITHKLINE BEECHAM CORPORATION (US) 1993-10-28 WO disclosed